Impact of Ambulatory Blood Pressure Monitoring on Reclassification of Hypertension Prevalence and Control in Older People in Spain

Journal of Clinical Hypertension

Volumn 17, Issue 6, 2015, Pages 453-461

  Banegas, José R ^a   de la Cruz, Juan J ^a   Graciani, Auxiliadora ^a   López García, Esther ^a   Gijón Conde, Teresa ^a   Ruilope, Luis M ^a   Rodriguez Artalejo, Fernando ^a  

^a CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; BODY MASS; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE CLASSIFICATION; DRUG USE; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OSCILLOMETER; PHYSICAL INACTIVITY; PREVALENCE; PRIORITY JOURNAL; SMOKING; SPAIN; SPHYGMOMANOMETER; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; MIDDLE AGED; PROCEDURES;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE MONITORING, AMBULATORY; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PREVALENCE; SPAIN;

EID: 84931056226     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/jch.12525     Document Type: Article

References (46)

1. Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217-223.
2. Wolf-Maier K, Cooper RS, Banegas JR, et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA. 2003;289:2363-2369.
3. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2224-2260.
4. Pickering TG, Shimbo D, Haas D. Ambulatory blood-pressure monitoring. N Engl J Med. 2006;354:2368-2374.
5. Hansen TW, Kikuya M, Thijs L, et al; IDACO Investigators. Prognostic superiority of daytime ambulatory over conventional blood pressure in four populations: a meta-analysis of 7030 individuals. J Hypertens. 2007;25:1554-1564.
6. Burr ML, Dolan E, O'Brien EW, et al. The value of ambulatory blood pressure in older adults: the Dublin outcome study. Age Ageing. 2008;37:201-206.
7. O'Brien E. 24-h ambulatory blood pressure measurement in clinical practice and research: a critical review of a technique in need of implementation. J Intern Med. 2011;269:478-495.
8. Bombelli M, Toso E, Peronio M, et al. The Pamela study: main findings and perspectives. Curr Hypertens Rep. 2013;15:238-243.
9. Hozawa A, Ohkubo T, Kikuya M, et al. Blood pressure control assessed by home, ambulatory and conventional blood pressure measurements in the Japanese general population: the Ohasama study. Hypertens Res. 2002;25:57-63.
10. Banegas JR, Segura J, Sobrino J, et al. Effectiveness of blood pressure control outside the medical setting. Hypertension. 2007;49:62-68.
11. Franklin SS, Thijs L, Hansen TW, et al. White-coat hypertension: new insights from recent studies. Hypertension. 2013;62:982-987.
12. Bobrie G, Clerson P, Ménard J, et al. Masked hypertension: a systematic review. J Hypertens. 2008;26:1715-1725.
13. Giles TD, Black HR, Messerli F, White WB. Ambulatory blood pressure monitoring should be included in the National Health and Nutritional Examination Survey (NHANES). J Am Soc Hypertens. 2012;6:364-366.
14. National Institute for Health and Clinical Excellence. Hypertension: clinical management of primary hypertension in adults. London: NICE, 2011. http://guidance.nice.org.uk/CG127. Accessed February 26, 2014.
15. Rodríguez-Artalejo F, Graciani A, Guallar-Castillón P, et al. Rationale and methods of the Study on Nutrition and Cardiovascular Risk in Spain (ENRICA). Rev Esp Cardiol. 2011;64:876-882.
16. Falaschetti E, Mindell J, Knott C, Poulter N. Hypertension management in England: a serial cross-sectional study from 1994 to 2011. Lancet. 2014;383:1912-1919.
17. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA. 2003;290:199-206.
18. Parati G, Stergiou GS, Asmar R, et al. European Society of Hypertension practice guidelines for home blood pressure monitoring. J Hum Hypertens. 2010;24:779-785.
19. Mancia G, Bombelli M, Seravalle G, Grassi G. Diagnosis and management of patients with white-coat and masked hypertension. Nat Rev Cardiol. 2011;8:686-693.
20. Wareham NJ, Jakes RW, Rennie KL, et al. Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutr. 2003;6:407-413.
21. Pickering TG, Hall JE, Appel LJ, et al. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation. 2005;111:697-716.
22. Ragazzo F, Saladini F, Palatini P. Validation of the MicrolifeWatchBP O3 device for clinic, home, and ambulatory blood pressure measurement, according to the International Protocol. Blood Press Monit. 2010;15:59-62.
23. Mancia G, Fagard R, Narkiewicz K, et al. Task Force Members. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31:1281-1357.
24. O'Brien E, Parati G, Stergiou G, et al; On behalf of the European Society of Hypertension Working Group on Blood Pressure Monitoring. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens. 2013;31:1731-1768.
25. Mancia G, De Backer G, Dominiczak A, et al. Management of Arterial Hypertension of the European Society of Hypertension; European Society of Cardiology. 2007 Guidelines for the Management of Arterial Hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25:1105-1187.
26. Chobanian AV, Bakris GL, Black HL, et al. The National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-1252.
27. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA. 2010;303:2043-2050.
28. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307-310.
29. James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311:507-520.
30. Head GA, Mihailidou AS, Duggan KA, et al. Ambulatory Blood Pressure Working Group of the High Blood Pressure Research Council of Australia. Definition of ambulatory blood pressure targets for diagnosis and treatment of hypertension in relation to clinic blood pressure: prospective cohort study. BMJ. 2010;340:c1104.
31. http://www.ine.es/jaxiBD/tabla.do?per=01&type=db&divi=EPOB&idtab=1. Accessed June 25, 2014.
32. Sega R, Facchetti R, Bombelli M, et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation. 2005;111:1777-1783.
33. Banegas JR, Ruilope LM, Sierra A, et al. High prevalence of masked uncontrolled hypertension in people with treated hypertension. Eur Heart J. 2014;35:3304-3312.
34. Fagard RH. CornelissenVA. Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis. J Hypertens. 2007;25:2193-2198.
35. Llisterri JL, Alonso FJ, Gorostidi M, et al. en Representación de los Investigadores del Proyecto CARDIORISC-MAPAPRES. Sociedad Española de Hipertensión-Liga Española para la Lucha contra la Hipertensión Arterial (SEH-LELHA). Differences between office and ambulatory control of hypertension in very elderly patients. The CARDIORISC - MAPAPRES project. Med Clin (Barc). 2009;133:769-776.
36. Ben-Dov IZ, Ben-Arie L, Mekler J, Bursztyn M. In clinical practice, masked hypertension is as common as isolated clinic hypertension: predominance of younger men. Am J Hypertens. 2005;18(5 Pt 1):589-693.
37. Verdecchia P, Angeli F, Gattobigio R, et al. The clinical significance of white-coat and masked hypertension. Blood Press Monit. 2007;12:387-389.
38. Pierdomenico SD, Cuccurullo F. Prognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: an updated meta analysis. Am J Hypertens. 2011;24:52-58.
39. Mayor S. Hypertension diagnosis should be based on ambulatory blood pressure monitoring, NICE recommends. BMJ. 2011;343:d5421.
40. Lovibond K, Jowett S, Barton P, et al. Cost-effectiveness of options for the diagnosis of high blood pressure in primary care: a modelling study. Lancet. 2011;378:1219-1230.
41. Ernst ME, Bergus GR. Favorable patient acceptance of ambulatory blood pressure monitoring in a primary care setting in the United States: a cross-sectional survey. BMC Fam Pract. 2003;4:15.
42. McGreevy C, Mulrooney J, O′Keeffe ST, Mulkerrin EC. Do older people tolerate ambulatory blood pressure monitoring? J Am Geriatr Soc. 2004;52:1780-1781.
43. Giles TD, Sander GE. Diastolic blood pressure and hypertension phenotypes: the US Food and Drug Administration has it right. J Clin Hypertens (Greenwich). 2013;15:145-146.
44. Myers MG. Eliminating the human factor in office blood pressure measurement. J Clin Hypertens (Greenwich). 2014;16:83-86.
45. Márquez Contreras E, Gil Guillén V, Casado Martínez JJ, et al. Analysis of studies published on hypertension treatment non-compliance in Spain between 1984 and 2005. Aten Primaria. 2006;38:325-332.
46. O′Brien E. First Thomas Pickering Memorial Lecture: ambulatory blood pressure measurement is essential for the management of hypertension. J Clin Hypertens (Greenwich). 2012;14:836-847.